Weekly Debrief#91 min read

Week of Mar 02-06, 2026

Weekly Intelligence Debrief

Dental

XRAY-11.5%
NVST-6.9%
ALGN-5.7%
HSIC-4.0%

Payers & Insurance

ELV-8.1%
CI-5.5%
HUM-4.9%
MOH-4.7%
CVS-2.5%

Hospital Systems & Providers

ACHC+10.2%
SEM+9.8%
UHS-5.2%
DVA-2.8%
HCA+0.5%

Healthcare Services & Tech

GDRX+26.7%
VEEV+8.5%
HIMS+8.5%
AGL+6.8%
PGNY+6.0%

Week-over-week change

The market is paying a premium for revenue visibility and regulatory insulation — and punishing everything else. Veeva and Acadia proved earnings beats still get rewarded, but you need a clean regulatory profile to hold the gains. The payer trade is in regulatory purgatory until CMS/Elevance resolves. Dental supply is collateral damage from geopolitics, not fundamentals.

Theme Clusters

  • 1Regulatory risk repricing across Medicare Advantage — Elevance sanctions created sector-wide contagion
  • 2Healthcare IT proving defensive in volatile markets — Veeva's 16% revenue growth and CRM migration driving premium
  • 3Behavioral health inflection — Acadia's bed expansion and short squeeze dynamics signal sector bottom

This Week's Daily Editions

Capital Pulse — Market Data

Price tables, sector analyses, macro patterns, and watchlist signals for the week of Mar 02-06, 2026.

Get The Healthcare Edge in your inbox

Daily intelligence for dental professionals. Free, forever.